Eloy obtained his bachelor’s degree in Biomedicine at the University of Barcelona. Shortly after, he carried out a master’s program in Biomedicine and Cancer Research at the Faculty of Medicine of the Hospital Clínic of Barcelona.
At the end of his bachelor, he performed a one-year internship at the Netherlands Cancer Institute (NKI) in Amsterdam. His research activity was mainly focused on the study of the sensitivity of several molecular inhibitors in combination with the standard of care treatment in Glioblastoma. As part of his master’s internship, Eloy collaborated with a prestigious research group at the Josep Carreras Leukaemia foundation in Barcelona, dedicated to find new therapies for Leukaemia. He studied the depletion of cancer stem cells in leukaemia using Bromocriptine, a dopamine agonist used to treat pituitary tumors and other diseases such as Parkinson.
In 2014, he received his master’s degree and shortly thereafter, he relocated to the Netherlands to commence a PhD track under the supervision of prof. Marc Vooijs at the department of radiation oncology, Maastricht University. His research involved basic and therapeutic aspects of the HIF and NOTCH signaling pathways for cancer treatment. One of the most exciting achievements of his PhD was the generation of several knock-out cell lines using the CRISPR/CAS9 technology for a set of different oncogenes.
Eloy speaks English, Spanish, Italian and Catalan fluently and has working knowledge of Dutch. His main passion is travelling but he also enjoys a large set of activities such as CrossFit training, trekking, chess and hanging out with friends.